Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
Fisher
M J
MJ
Gazzard
B G
BG
Hawkins
D A
DA
Nelson
M R
MR
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000935:Antifungal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D006801:Humans; D016867:Immunocompromised Host; D009285:Naphthoquinones / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*
D000935:Antifungal Agents; D009285:Naphthoquinones; D053626:Atovaquone